Integrated Diagnostics Characterization of Right Ventricular Diastolic Flow Dynamics in Pulmonary Arterial Hypertension
NCT01491646 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 25
Last updated 2020-10-22
Summary
Pulmonary hypertension (PH) is a condition in which high blood pressure develops in the lungs and right side of the heart. People with PH suffer from shortness of breath, chest pain, heart failure, heart rhythm problems, and fainting. PH is diagnosed using a test called a cardiac catheterization where blood pressure is measured directly using a tube placed in the right side of the heart and lung arteries. Because a cardiac catheterization is invasive, researchers are investigating ways to diagnose PH using imaging tests that are not invasive. The study will evaluate whether or not a magnetic resonance image (MRI) of the heart, and blood tests can detect PH.
Conditions
- Pulmonary Hypertension
Sponsors & Collaborators
-
Siemens Medical Solutions
collaborator INDUSTRY -
National Jewish Health
lead OTHER
Principal Investigators
-
Brett Fenster, MD, FACC, FACP · National Jewish Health
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2010-11-30
- Primary Completion
- 2013-10-31
- Completion
- 2013-10-31
Countries
- United States
Study Locations
More Related Trials
-
Characterization of LV Strain Patterns in Mildly Elevated PCWP and PAH.
NCT01800292 ·Status: COMPLETED ·Phase: PHASE4
-
Dynamic Assessment of Right Ventricular Function With Inhaled Nitric Oxide During Cardiac MRI
NCT02220023 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Feasibility of Slow-paced Respiration Therapy for Treatment of a Symptom Cluster in Pulmonary Arterial Hypertension
NCT02080533 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
The Effects of Pulmonary Hypertension Web-Based Health Care Program on Symptom Management, Social Support, Activity Tolerance, and Quality of Life in Patients With Pulmonary Hypertension.
NCT05908019 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of Lung Doppler Signals in Pulmonary Hypertension
NCT01839786 ·Status: TERMINATED
-
Clinical Profile of Patients With Pulmonary Hypertension Due to Lung Diseases ( Single Center Experience)
NCT02774928 ·Status: UNKNOWN
-
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
NCT06388421 ·Status: RECRUITING
-
Pulmonary Hypertension--Mechanisms and Family Registry
NCT00005357 ·Status: COMPLETED
-
Utility of Exercise-induced N-terminal (NT) Pro-brain Natriuretic Peptide Levels in Predicting Prognosis in Asymptomatic Aortic Stenosis
NCT00567437 ·Status: TERMINATED ·Phase: NA
-
Oral Nitrite in Patients With Pulmonary Hypertension and Heart Failure With Preserved Ejection Fraction
NCT03015402 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of iNO on Invasively Derived Pulmonary Pressures in Patients With PAH
NCT02734953 ·Status: COMPLETED ·Phase: PHASE2
-
Responsiveness of Exercise Tests in Pulmonary Arterial Hypertension
NCT01391104 ·Status: COMPLETED ·Phase: NA
-
Study Of Right Ventricular Performance In PAH Patients Treated With Rapid Dose Treprostinil (Remodulin)
NCT02074449 ·Status: COMPLETED
-
Right Ventricular Pacing in Pulmonary Arterial Hypertension
NCT04194632 ·Status: UNKNOWN ·Phase: NA
-
Stress Ventricular Function in Evaluating Patients With Pulmonary Hypertension
NCT02647034 ·Status: UNKNOWN
-
Repeatability and Sensitivity to Change of Non-invasive Endpoints in PAH
NCT03841344 ·Status: UNKNOWN ·Phase: NA
-
3 Part Study to Assess Inhaled Nitric Oxide on Functional Pulmonary Imaging in Subj. Pulmonary Hypertension Associated w/ COPD and IPF
NCT02267655 ·Status: COMPLETED ·Phase: PHASE1
-
PAHTCH Pulmonary Arterial Hypertension Treatment With Carvedilol for Heart Failure (Carvedilol)
NCT01586156 ·Status: COMPLETED ·Phase: NA
-
The Exercise Capacity and Quality of Life in the Patients With IPAH and Secondary PH
NCT02647060 ·Status: COMPLETED
-
Effect iNO on Functional Respiratory Imaging in Subjects With WHO Group 3 Pulmonary Hypertension With COPD on Oxygen
NCT03135860 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Repurposing a Histamine Antagonist to Benefit Patients With Pulmonary Hypertension
NCT03554291 ·Status: COMPLETED ·Phase: PHASE2
-
Acute Exposure of High Altitude on Cardiac Output
NCT03637218 ·Status: COMPLETED ·Phase: NA
-
Imaging Control Study, 3D Echo, MR and RHC.
NCT02198456 ·Status: UNKNOWN
-
Study of Ranolazine in the Treatment of Pulmonary Hypertension Associated With Diastolic Left Ventricular Dysfunction
NCT02133352 ·Status: COMPLETED ·Phase: PHASE4
-
Acute Excposure of High Altitude on ECG and Non-invasive Blood Pressure.
NCT03593083 ·Status: COMPLETED ·Phase: NA